Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials
Open Access
- 13 June 2025
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 27 (10) , 1219-1228
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (P30 GM103326)
- National Institute of General Medical Sciences (GM130423)
- University of Kansas Medical Center
This publication has 38 references indexed in Scilit:
- A large‐scale production of mesenchymal stem cells and their exosomes for an efficient treatment against lung inflammationBiotechnology Journal, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Production cell analysis and compound‐based boosting of small extracellular vesicle secretion using a generic and scalable production platformBiotechnology and Bioengineering, 2023
- Suppression of PD‐L1 release from small extracellular vesicles promotes systemic anti‐tumor immunity by targeting ORAI1 calcium channelsJournal of Extracellular Vesicles, 2022
- Large‐scale production of extracellular vesicles: Report on the “massivEVs” ISEV workshopJournal of Extracellular Biology, 2022
- WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1Journal of Extracellular Vesicles, 2021
- Scaled Isolation of Mesenchymal Stem/Stromal Cell‐Derived Extracellular VesiclesCurrent Protocols in Stem Cell Biology, 2020
- A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host DiseaseStem Cell Reviews and Reports, 2020
- Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell PopulationsStem Cells, 2017
- Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathwayEuropean Journal of Immunology, 2005